Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

New indication for celecoxib (Celebrex) by Pfizer. The FDA has approved the selective COX-2 inhibitor celecoxib (Celebrex) for a new indication, the relief of the signs and symptoms associated with ankylosing spondylitis.

New FDA Approvals